{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:31:25Z","timestamp":1793968285772,"version":"4.8.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.jcyt.2026.102978","type":"journal-article","created":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T15:13:44Z","timestamp":1785942824000},"page":"102978","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Automating chimeric antigen receptor T-cell manufacturing across distinct platforms delivers similar cell quality, phenotype and function"],"prefix":"10.1016","volume":"28","author":[{"given":"Eu Han","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Safford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terri","family":"Staab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min Sung","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-1827-3351","authenticated-orcid":false,"given":"Mack","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Pleitez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3081-6978","authenticated-orcid":false,"given":"Alex","family":"Sargent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2026.102978_bib0001","first-page":"101","article-title":"CAR T-cell therapy: a promising novel approach for treatment of cancer","volume":"47","author":"Posa","year":"2026","journal-title":"Cancer Treat Res Commun"},{"key":"10.1016\/j.jcyt.2026.102978_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.omtm.2024.101250","article-title":"CAR-T cell manufacturing landscape\u2014lessons from the past decade and considerations for early clinical development","volume":"32","author":"Dias","year":"2024","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jcyt.2026.102978_bib0003","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.876339","article-title":"Impact of manufacturing procedures on CAR T cell functionality","volume":"13","author":"Watanabe","year":"2022","journal-title":"Front Immunol"},{"key":"10.1016\/j.jcyt.2026.102978_bib0004","first-page":"180","article-title":"Living medicines engineered to fight: a comprehensive review on CAR T-cell therapy","volume":"19","author":"Vinoo","year":"2025","journal-title":"Int J Hematol Oncol Stem Cell Res"},{"key":"10.1016\/j.jcyt.2026.102978_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/mto.2016.15","article-title":"Clinical manufacturing of CAR T cells: foundation of a promising therapy","volume":"3","author":"Wang","year":"2016","journal-title":"Mol Ther Oncolytics"},{"key":"10.1016\/j.jcyt.2026.102978_bib0006","doi-asserted-by":"crossref","DOI":"10.1084\/jem.20230903","article-title":"CAR-T cell manufacturing: major process parameters and next-generation strategies","volume":"221","author":"Ayala Ceja","year":"2024","journal-title":"J Exp Med"},{"key":"10.1016\/j.jcyt.2026.102978_bib0007","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.jcyt.2024.03.003","article-title":"CAR-T cell expansion platforms yield distinct T cell differentiation states","volume":"26","author":"Song","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102978_bib0008","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1158\/2326-6066.CIR-21-0501","article-title":"Modified manufacturing process modulates CD19CAR T-cell engraftment fitness and leukemia-free survival in pediatric and young adult subjects","volume":"10","author":"Ceppi","year":"2022","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/j.jcyt.2026.102978_bib0009","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41591-018-0010-1","article-title":"Determinants of response and resistance to CD19 chimeric antigen receptor (CAR) T cell therapy of chronic lymphocytic leukemia","volume":"24","author":"Fraietta","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/j.jcyt.2026.102978_bib0010","article-title":"Industrializing CAR-T cell therapy: impact of automation on cost and space efficiency of manufacturing facilities","volume":"13","author":"Weltin","year":"2025","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/j.jcyt.2026.102978_bib0011","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1158\/2643-3230.BCD-21-0084","article-title":"Scalable manufacturing of CAR T cells for cancer immunotherapy","volume":"2","author":"Abou-El-Enein","year":"2021","journal-title":"Blood Cancer Discov"},{"key":"10.1016\/j.jcyt.2026.102978_bib0012","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.omtm.2023.101114","article-title":"Development of an automated manufacturing process for large-scale production of autologous T cell therapies","volume":"31","author":"Francis","year":"2023","journal-title":"Mol Ther Methods Clin Dev"},{"key":"10.1016\/j.jcyt.2026.102978_bib0013","article-title":"Transition from manual to automated processes for autologous T cell therapy manufacturing using bioreactor with expandable culture area","volume":"15","author":"Lee","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2026.102978_bib0014","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.jcyt.2024.07.006","article-title":"Automation preserves product consistency and quality for the formulation, fill, and finish of T cell-based therapies","volume":"26","author":"Park","year":"2024","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2026.102978_bib0015","doi-asserted-by":"crossref","first-page":"584","DOI":"10.21037\/atm.2020.02.148","article-title":"Pre-clinical assessment of chimeric antigen receptor T cell therapy targeting CD19+ B cell malignancy","volume":"8","author":"Hu","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/j.jcyt.2026.102978_bib0016","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00262-024-03753-y","article-title":"In vitro CAR-T cell killing: validation of the potency assay","volume":"73","author":"Piccinini","year":"2024","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/j.jcyt.2026.102978_bib0017","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s10616-015-9889-2","article-title":"Using simple models to describe the kinetics of growth, glucose consumption, and monoclonal antibody formation in naive and infliximab producer CHO cells","volume":"68","author":"L\u00f3pez-Meza","year":"2016","journal-title":"Cytotechnology"},{"key":"10.1016\/j.jcyt.2026.102978_bib0018","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1186\/s12967-025-06836-1","article-title":"Optimizing T cell transduction: a novel transduction device for efficient and scalable gene delivery","volume":"23","author":"Lee","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/j.jcyt.2026.102978_bib0019","article-title":"Optimized conditions for gene transduction into primary immune cells using viral vectors","volume":"13","author":"Kim","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2026.102978_bib0020","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-019-50981-9","article-title":"A microfluidic device to enhance viral transduction efficiency during manufacture of engineered cellular therapies","volume":"9","author":"Moore","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/j.jcyt.2026.102978_bib0021","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.apsb.2020.10.020","article-title":"CAR-T cells: early successes in blood cancer and challenges in solid tumors","volume":"11","author":"Dana","year":"2021","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/j.jcyt.2026.102978_bib0022","doi-asserted-by":"crossref","DOI":"10.1016\/j.medj.2026.101028","article-title":"Current state of CAR-T cell therapies for solid tumors","volume":"7","author":"Rosa","year":"2026","journal-title":"Med"},{"key":"10.1016\/j.jcyt.2026.102978_bib0023","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13036-026-00666-5","article-title":"Are we there yet? The road to faster and more efficient CAR T cell manufacturing","volume":"20","author":"Matos","year":"2026","journal-title":"J Biol Eng"},{"key":"10.1016\/j.jcyt.2026.102978_bib0024","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/S2352-3026(24)00273-4","article-title":"Accelerating and optimising CAR T-cell manufacture to deliver better patient products","volume":"12","author":"Agliardi","year":"2025","journal-title":"Lancet Haematol"},{"key":"10.1016\/j.jcyt.2026.102978_bib0025","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.jbiotec.2022.10.004","article-title":"Metabolic rewiring revealed by cell-specific rate analyses from nontargeted exometabolomics during simultaneous consumption of glucose and lactic acid in a CHO fed-batch process","volume":"359","author":"Luo","year":"2022","journal-title":"J Biotechnol"},{"key":"10.1016\/j.jcyt.2026.102978_bib0026","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1038\/s41423-024-01148-8","article-title":"Cellular metabolism regulates the differentiation and function of T-cell subsets","volume":"21","author":"Ma","year":"2024","journal-title":"Cell Mol Immunol"},{"key":"10.1016\/j.jcyt.2026.102978_bib0027","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.coi.2010.01.018","article-title":"Metabolism in T cell activation and differentiation","volume":"22","author":"Pearce","year":"2010","journal-title":"Curr Opin Immunol"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926009394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324926009394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T12:22:57Z","timestamp":1793967777000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324926009394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":27,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["S1465324926009394"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102978","relation":{},"ISSN":["1465-3249"],"issn-type":[{"value":"1465-3249","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automating chimeric antigen receptor T-cell manufacturing across distinct platforms delivers similar cell quality, phenotype and function","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2026.102978","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Inc. on behalf of International Society for Cell & Gene Therapy.","name":"copyright","label":"Copyright"}],"article-number":"102978"}}